The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sun., Apr. 20, 7:48 PM

Slide #8. Regado Biosciences, Inc. Secondary Offering

Company: Regado Biosciences, Inc. (NASDAQ:RGDO)
Date announced: 4/11/2014
Shares Offered: 10,000,000
Date of Pricing: 4/11/2014
Price Per Share: $6
Secondary Offering Details: Regado Biosciences, Inc. (Nasdaq: RGDO), today announced the pricing of its previously announced underwritten public offering of 10,000,000 shares of its common stock, offered at a price of $6.00 per share to the public. The gross proceeds to Regado from this offering are expected to be approximately $60.0 million, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by Regado. The offering is expected to close on or about April 16, 2014, subject to the satisfaction of customary closing conditions. Regado has granted the underwriters a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock. Regado expects to use the net proceeds of this offering to fund further clinical development of its lead product candidate, REG1, and for working capital and other general corporate purposes.

Regado BioSciences is a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications. Co. is pioneering the discovery and development of two-component drug systems consisting of a therapeutic aptamer and its specific active control agent. Co.'s actively controllable product candidates have the potential to improve outcomes, enhance the patient experience and reduce overall treatment costs. Each of Co.'s product candidates consists of a two-component system: an antithrombotic aptamer and its specific active control agent.
Open the RGDO Page at The Online Investor »

Company Name:  Regado BioSciences Inc
Sector:  Biotechnology

Open the RGDO Page at The Online Investor (in a new window) »

April 20, 2014    7:48 PM Eastern
Quotes delayed 20 minutes

Trade RGDO Now:

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.